Noninfectious uveitis: Meeting the challenge

Chronic cases can be difficult for retina specialists; treatment is satisfying.

Improving patient comfort with intravitreal injections

Use of anxiety-screening questionnaires in patients needing intravitreal anti-VEGF injections may help to identify individuals at risk for elevated pain during the procedure, according to research presented at ARVO 2020.

Antihyperglycemic drug associated with reduced risk of new onset AMD

A large case-control study found that among adults aged 55 years and older, the use of metformin significantly decreased the risk of being newly diagnosed with age-related macular degeneration within 2 years.

Identifying risk factors for severe diabetic eye disease

July 01, 2020

An analysis using a large commercial claims database found that almost 3% of patients developed severe diabetic eye disease within 5 years of being diagnosed with type 2 diabetes. Clinical and demographic risk factors were also identified.

New Protocol V findings offer guidance for managing DME

July 01, 2020

A new analysis from the DRCR Network Protocol V showed that many patients with center-involved diabetic macular edema and good vision do not require treatment for visual acuity loss.

Face-down positioning better after detached retina repair

June 29, 2020

Face-down positioning is associated with a reduction in certain complications following macula-involving retinal displacement (RD) repair, according to researchers.

Subretinal gene therapy safe with visual benefit

June 18, 2020

This study provided clinical proof of concept for viral vector-mediated gene supplementation therapy of inherited day blindness caused by pathogenic variants in the cone photoreceptor-specific gene CNGA3.

ST laser therapy may reduce DME intravitreal injections

June 18, 2020

Used as an adjunct, ST laser therapy may reduce the treatment burden for patients while maintaining visual acuity.